Task force recommends clinicians offer high-risk patients pill to prevent HIV
The U.S. Preventive Services Task Force yesterday issued a draft recommendation that clinicians offer pre-exposure prophylaxis (PrEP), a daily pill that helps prevent HIV, to people at high risk for HIV. The task force also continued to recommend that clinicians screen all Americans aged 15 to 65 and pregnant women for HIV, as well as younger adolescents and older adults at increased risk for the virus. The panel will accept comments on the draft recommendations through Dec. 26.
Related News Articles
Headline
The Food and Drug Administration has approved a blood test for detecting Alzheimer’s by Roche and Eli Lilly, according to an announcement Aug. 24 by Roche. The…
Blog
By Rani E. Snyder, President, The John A. Hartford Foundation and Dr. Chris DeRienzo, AHA Chief Physician Executive/President of AHA’s HRET As the U.S.…
Headline
The Department of Health and Human Services Aug. 14 announced that three health systems have signed the agency’s voluntary pledge related to hospital efforts…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. Aug. 7 declared a public health emergency for Washington state to address the impacts…
Chairperson's File
We all deserve safe, evidence-based healthcare focused on what matters to us as we age. The AHA is working with several partners to ensure it occurs across…
Headline
The Consumer Product Safety Commission yesterday announced it is modernizing the National Electronic Injury Surveillance System, the national database for…